TY - JOUR T1 - Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case–control study JF - European Journal of Hospital Pharmacy JO - Eur J Hosp Pharm SP - e2 LP - e5 DO - 10.1136/ejhpharm-2021-002776 VL - 29 IS - e1 AU - Carla Codina-Jiménez AU - Sergio Marin AU - Marlene Álvarez AU - Maria Dolores Quesada AU - Beatriz Rodríguez-Ponga AU - Ester Valls AU - Carles Quiñones Y1 - 2022/03/01 UR - http://ejhp.bmj.com/content/29/e1/e2.abstract N2 - Background Nosocomial bloodstream infection (nBSI) is an important clinical concern among COVID-19 hospitalised patients. It can cause sepsis and septic shock leading to high morbidity, mortality, and the emergence of antibiotic resistance. The aim of this case–control study is to identify the risk factors associated with the nBSI development in COVID-19 hospitalised patients and its incidence.Methods and analysis A retrospective case–control study will be performed. Cases will include nBSI episodes of adult patients (≥18 years) admitted to Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, from April to December 2020 with a diagnosis of SARS-CoV-2 pneumonia. Patients transferred from other hospitals will be excluded. Controls will include hospitalisation episodes of COVID-19 patients without nBSI. We will recruit a minimum of 74 nBSI episodes (cases) and 74 controls (according to sample size calculation). We will collect data on sociodemographics, clinical status at admission, hospital admission, in-hospital mortality, and exposure data (use of antivirals, glucocorticoids or immunomodulatory agents, length of hospitalisation, and use of medical devices such as intravenous catheters). A bivariate and a subsequent multivariate regression analysis will be performed to assess the independent effect of the associated risk factors after adjusting for confounders. The nBSI incidence rate will be estimated according to the number of nBSI episodes in admitted COVID-19 patients among the total person-month of follow-up.Ethics and dissemination The protocol of this study was approved by the Ethical Committee for Drug Investigation of the Hospital Universitari Germans Trias i Pujol. The results of this case–control study will be published in a peer reviewed journal. ER -